{
    "2018-03-01": [
        [
            {
                "time": "2018-02-28",
                "original_text": "中泰证券3月各行业观点及重点推荐标的",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "行业观点",
                        "重点推荐"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "【医药】江琦：医药生物行业2018年3月月报：以业绩为导向，以创新为方向",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩导向",
                        "创新方向"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}